Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Stemline Therapeutics Inc. STML

Healthcare Biotechnology
Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is involved in the business of discovering, acquiring and developing and commercializing therapeutics for oncology indications of unmet medical need. Its pipeline product candidates include felezonexor (SL-801, an XPO1 inhibitor), SL-1001 (a RET kinase inhibitor), SL-901 (a kinase inhibitor) and SL-701 (an... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:STML)

SHAREHOLDER ALERT: WeissLaw LLP Reminds STML, PTLA, and QES Shareholders About Its Ongoing Investigations

GlobeNewswire May 21, 2020

NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: QUINTANA ENERGY SERVICES, INC. (NYSE - QES), STEMLINE THERAPEUTICS, INC. (NASDAQ - STML) AND resTORbio, Inc. (NasdaqGS - TORC)

ACCESSWIRE IA May 19, 2020

STEMLINE ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of STML and Encourages Investors to Contact the Firm

GlobeNewswire May 19, 2020

KLXE, FSB, PTLA, and STML SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers

GlobeNewswire May 19, 2020

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Stemline Pharmaceuticals, Inc. (NasdaqGS - STML)

ACCESSWIRE IA May 18, 2020

INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - STML, KLXE, PTLA

ACCESSWIRE IA May 16, 2020

Lifshitz Law Firm, P.C. Announces Investigation of KLX Energy Services Holdings, Inc. (KLXE), Quintana Energy Services, Inc. (QES), Portola Pharmaceuticals, Inc. (PTLA), and Stemline Therapeutics, Inc. (STML)

GlobeNewswire May 15, 2020

INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm

PR Newswire May 15, 2020

NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: QUINTANA ENERGY SERVICES, INC. (NYSE - QES), STEMLINE THERAPEUTICS, INC. (NASDAQ - STML) AND WILLIS TOWERS WATSON, PLC (NASDAQ - WLTW)

ACCESSWIRE IA May 14, 2020
View More News ››

Opinion & Analysis (NDAQ:STML)

Stemline Shares Take Off on $677 Million Buyout Offer by Global Pharmaceutical Firm

Streetwise Reports May 5, 2020

Biotech reports positive topline data; biologics license application in progress

Streetwise Reports November 8, 2017

2017 Small-Cap Biotech Watchlist update: up 21% at the end of Q2/17

The Life Sciences Report July 14, 2017

2017 Small-Cap biotech watchlist update: holding steady in a volatile market

The Life Sciences Report April 21, 2017

2017 Small-Cap Biotech Watchlist: takeaways for investors

The Life Sciences Report January 19, 2017

19 companies selected for the 2017 Small-Cap Biotech Watchlist

The Life Sciences Report January 5, 2017
View More Opinion ››

Bullboard Posts (NDAQ:STML)

watching this one to

see how low the share price can go so glta.
coolfooldumbguy - January 14, 2020

watching this one for

a bottoming out in share price and possible purchase later,so glta.
coolfooldumbguy - January 14, 2020
View more Bullboard ››

Gemina Laboratories Ltd.

Gemina Laboratories Ltd.

Gemina Laboratories Ltd. is a Canada-based biosensor and diagnostic company with a transformative, patented, proprietary ...
View More »